文献速递食管与纵隔外科

开放与微创Ivor Lewis食管切除术转换后的结局分析

An Analysis of Outcomes After Transition From Open to Minimally Invasive Ivor Lewis Esophagectomy.
PubMed 文献 · Ann Thorac Surg · 2020-09-01

该回顾性研究比较了259例食管癌患者接受微创Ivor Lewis食管切除术(M-ILE,n=173)与开放Ivor Lewis食管切除术(O-ILE,n=86)的结局。两组3年总生存率和无复发生存率无显著差异。

核心结论

  • M-ILE在短期临床结局上优于O-ILE,但生存率和无复发生存率无显著差异。

研究设计与样本

  • 回顾性研究,纳入2009年4月至2019年3月259例食管癌患者,M-ILE组173例,O-ILE组86例。
  • 采用逆概率处理加权(IPTW)调整基线特征,IPTW队列共249例(M-ILE 163例,O-ILE 86例)。
  • 按意向治疗原则比较无复发生存率和总生存率。

临床怎么用

  • 在心胸外科临床中,M-ILE可作为食管癌切除术的可选术式,其短期结局优于开放手术。
  • 需注意M-ILE与O-ILE的长期生存和无复发生存无显著差异。

局限性

  • 本研究为单中心回顾性研究,可能存在选择偏倚。
  • 样本量有限,M-ILE组173例,O-ILE组86例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The morbidity and mortality remain relatively high for transthoracic esophagectomy with open thoracotomy. We compared a total laparoscopic and thoracoscopic minimally invasive Ivor Lewis esophagectomy (M-ILE) cohort with a propensity score-weighted cohort of open Ivor Lewis esophagectomy (O-ILE) cases. METHODS: This is a retrospective review of 259 patients diagnosed with esophageal carcinoma who underwent M-ILE (n = 173) or O-ILE (n = 86) from April 2009 to March 2019. The postoperative morbidity and mortality were reported for each group. Inverse probability of treatment weighting (IPTW) adjustment was used to balance the baseline characteristics between study groups. Recurrence-free and overall survival rates were compared on an intention-to-treat basis. RESULTS: The IPTW cohort included 249 patients with esophageal carcinoma who underwent M-ILE (n = 163) or O-ILE (n = 86). The overall rate of postoperative adverse events was significantly higher after IPTW adjustment in the O-ILE group (54.2% vs 39.02%; P = .039). The median hospital length of stay was 8.0 (interquartile range, 7.0-9.0) days for the M-ILE group compared with 10.0 (interquartile range, 8.0-14.0) days for the O-ILE group (P < .001). The 3-year overall survival for the M-ILE group was 64.63% (95% confidence interval, 54.7%-72.9%) compared with 54.76% (95% confidence interval, 39.9%-67.4%) for the O-ILE group (P = .447). The 3-year recurrence-free survival rate did not differ significantly between the groups (P = .461). CONCLUSIONS: The M-ILE approach demonstrated short-term clinical outcomes that were superior to O-ILE at our institution. The survival rate and recurrence-free survival rate for M-ILE were not significantly different from O-ILE for esophageal carcinoma.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Merritt RE, Kneuertz PJ, D'Souza DM, et al. An Analysis of Outcomes After Transition From Open to Minimally Invasive Ivor Lewis Esophagectomy. Ann Thorac Surg. 2020. PMID: 32888925. doi:10.1016/j.athoracsur.2020.06.071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。